Sounds lIke Rabin suggesting good news on many patients?
Could this be the catalyst for share price to soar?!
Rabin: "Some of them have seen the charts that show the improved visual acuity in a lot of the patients for a month, two months, three months, six months and some for more than a year, coming up on two years"
Specifically, in regard to the patient who improved from 20/400 to 20/40, they are now saying that wasn't typical but related to a specific condition with that patient. Since the original news caused the stock to rise, it stands to reason it will now drop, perhaps drastically.
because of how the news article is tagged (and emtnions these other companies) it is showing up in the Pfizer, MRK etc news feeds on yahoo and elsewhere. this is going to give ACTC more exposure and potentially increase investor awareness.